A Pfs48/45-based vaccine to block Plasmodium falciparum transmission: phase 1, open-label, clinical trial

202413 citationsJournal Articlegold Open Access

Authors

The trial is registered with ClinicalTrials.gov under identifier NCT04862416.

Good health and well-being

Published in: BMC Medicine

Volume 22, Issue 1, pp. 170-170

Field-Weighted Citation Impact: 7.20